Comparative in vivo antiangiogenic effects of calreticulin from Trypanosoma cruzi and Homo sapiens sapiens

Angiogenesis is a complex multi-step process of neovascularization arising from preexisting blood vessels whose generation is regulated by pro- and anti-angiogenic factors. Both Trypanosoma cruzi calreticulin (TcCRT) and its human counterpart (HuCRT) are antiangiogenic. This is the first report wher...

Full description

Bibliographic Details
Main Authors: Victor Toledo, Galia Ramírez, Carolina Valck, Nandy López, Carolina H Ribeiro, Ismael Maldonado, Lorena Aguilar, David Lemus, Arturo Ferreira
Format: Article
Language:English
Published: BMC 2010-01-01
Series:Biological Research
Subjects:
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602010000300004
_version_ 1818526041547735040
author Victor Toledo
Galia Ramírez
Carolina Valck
Nandy López
Carolina H Ribeiro
Ismael Maldonado
Lorena Aguilar
David Lemus
Arturo Ferreira
author_facet Victor Toledo
Galia Ramírez
Carolina Valck
Nandy López
Carolina H Ribeiro
Ismael Maldonado
Lorena Aguilar
David Lemus
Arturo Ferreira
author_sort Victor Toledo
collection DOAJ
description Angiogenesis is a complex multi-step process of neovascularization arising from preexisting blood vessels whose generation is regulated by pro- and anti-angiogenic factors. Both Trypanosoma cruzi calreticulin (TcCRT) and its human counterpart (HuCRT) are antiangiogenic. This is the first report where the TcCRT and HuCRT anti-angiogenic properties are compared in vivo. In the chick embryonic chorioallantoid membrane assay (CAM) and at equimolar concentrations, TcCRT displayed significantly higher antiangiogenic activities than its human counterpart. LPS had marginal effects at the concentrations present in the recombinant protein preparations and the TcCRT antiangiogenic effects were largely inhibited by specific polyclonal antibodies, thus, reinforcing the fact that the observed TcCRT effects can be attributed to the parasite-derived molecule and not to the endotoxin. The antiangiogenic TcCRT effects correlate with its anti-tumor in vivo effects, as recently shown in our laboratory.
first_indexed 2024-12-11T06:17:34Z
format Article
id doaj.art-70ca5568f853431ba2c4fba4971ddaf7
institution Directory Open Access Journal
issn 0716-9760
0717-6287
language English
last_indexed 2024-12-11T06:17:34Z
publishDate 2010-01-01
publisher BMC
record_format Article
series Biological Research
spelling doaj.art-70ca5568f853431ba2c4fba4971ddaf72022-12-22T01:17:56ZengBMCBiological Research0716-97600717-62872010-01-01433287289Comparative in vivo antiangiogenic effects of calreticulin from Trypanosoma cruzi and Homo sapiens sapiensVictor ToledoGalia RamírezCarolina ValckNandy LópezCarolina H RibeiroIsmael MaldonadoLorena AguilarDavid LemusArturo FerreiraAngiogenesis is a complex multi-step process of neovascularization arising from preexisting blood vessels whose generation is regulated by pro- and anti-angiogenic factors. Both Trypanosoma cruzi calreticulin (TcCRT) and its human counterpart (HuCRT) are antiangiogenic. This is the first report where the TcCRT and HuCRT anti-angiogenic properties are compared in vivo. In the chick embryonic chorioallantoid membrane assay (CAM) and at equimolar concentrations, TcCRT displayed significantly higher antiangiogenic activities than its human counterpart. LPS had marginal effects at the concentrations present in the recombinant protein preparations and the TcCRT antiangiogenic effects were largely inhibited by specific polyclonal antibodies, thus, reinforcing the fact that the observed TcCRT effects can be attributed to the parasite-derived molecule and not to the endotoxin. The antiangiogenic TcCRT effects correlate with its anti-tumor in vivo effects, as recently shown in our laboratory.http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602010000300004CalreticulinT. cruzianti-angiogenesis
spellingShingle Victor Toledo
Galia Ramírez
Carolina Valck
Nandy López
Carolina H Ribeiro
Ismael Maldonado
Lorena Aguilar
David Lemus
Arturo Ferreira
Comparative in vivo antiangiogenic effects of calreticulin from Trypanosoma cruzi and Homo sapiens sapiens
Biological Research
Calreticulin
T. cruzi
anti-angiogenesis
title Comparative in vivo antiangiogenic effects of calreticulin from Trypanosoma cruzi and Homo sapiens sapiens
title_full Comparative in vivo antiangiogenic effects of calreticulin from Trypanosoma cruzi and Homo sapiens sapiens
title_fullStr Comparative in vivo antiangiogenic effects of calreticulin from Trypanosoma cruzi and Homo sapiens sapiens
title_full_unstemmed Comparative in vivo antiangiogenic effects of calreticulin from Trypanosoma cruzi and Homo sapiens sapiens
title_short Comparative in vivo antiangiogenic effects of calreticulin from Trypanosoma cruzi and Homo sapiens sapiens
title_sort comparative in vivo antiangiogenic effects of calreticulin from trypanosoma cruzi and homo sapiens sapiens
topic Calreticulin
T. cruzi
anti-angiogenesis
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602010000300004
work_keys_str_mv AT victortoledo comparativeinvivoantiangiogeniceffectsofcalreticulinfromtrypanosomacruziandhomosapienssapiens
AT galiaramirez comparativeinvivoantiangiogeniceffectsofcalreticulinfromtrypanosomacruziandhomosapienssapiens
AT carolinavalck comparativeinvivoantiangiogeniceffectsofcalreticulinfromtrypanosomacruziandhomosapienssapiens
AT nandylopez comparativeinvivoantiangiogeniceffectsofcalreticulinfromtrypanosomacruziandhomosapienssapiens
AT carolinahribeiro comparativeinvivoantiangiogeniceffectsofcalreticulinfromtrypanosomacruziandhomosapienssapiens
AT ismaelmaldonado comparativeinvivoantiangiogeniceffectsofcalreticulinfromtrypanosomacruziandhomosapienssapiens
AT lorenaaguilar comparativeinvivoantiangiogeniceffectsofcalreticulinfromtrypanosomacruziandhomosapienssapiens
AT davidlemus comparativeinvivoantiangiogeniceffectsofcalreticulinfromtrypanosomacruziandhomosapienssapiens
AT arturoferreira comparativeinvivoantiangiogeniceffectsofcalreticulinfromtrypanosomacruziandhomosapienssapiens